This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Orange And Morpho Will Unveil Significant Breakthrough For Healthcare Data Mobility At Mobile World Congress

Orange, through its healthcare services subsidiary Almerys, and Morpho (Safran group), a leader in identity management solutions and secure credentials, have jointly created the world’s first mobile identity management system for the healthcare sector, extending existing health card solutions.

The solution represents a significant breakthrough for healthcare data mobility, enabling secure access to patient data anytime, anywhere and on any device. A successful field trial is underway at Clermont Ferrand University Hospital Center (CHU) in France. The solution will be demonstrated on Feb. 25-28 at Mobile World Congress in Barcelona at GSMA Connected City located in Hall 3, Stands 3B2 and 3C2.

This healthcare data mobility solution from Orange and Morpho enables doctors to securely access patient files via a tablet or mobile device. The easy-to-use system uses strong SIM authentication to establish a link between the device’s SIM card and the physician’s unique identification number via the identity management platform. Once the SIM card is registered, an applet is directly loaded onto the mobile device or tablet that contains the SIM card. The doctor can then access patient files via a secure Web site by entering his phone number. A pop-up message requesting the physician’s unique identification number then appears in order to complete the authentication process.

Commenting on the field trial, Casimir Boyer, director of Information Systems for Clermont Ferrand University Hospital Center (CHU) in France, said: “We have chosen the identity authentication solution developed by Almerys, the Orange healthcare services entity, and Morpho because we think that this solution combines security, simplicity and mobility. We strongly need mobile access to our applications for the day-to-day activity of our healthcare team and our partners for which the CHU handles the results of biological analyses or other medical exams and who need to have the results as soon as possible.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,011.94 -28.43 -0.16%
S&P 500 2,109.60 -2.13 -0.10%
NASDAQ 5,076.5240 -6.4050 -0.13%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs